Table 1.
Attributes | Levels |
---|---|
Mode of administration | Injections twice a day in relation to meals |
Injection once a day in relation to meals | |
Injection once a day irrespective of meals | |
Oral antidiabetics (OAD) up to three times a day with meals | |
Blood glucose monitoring | Three times a day |
Once a day | |
Three times per week | |
No need for testing | |
Number of hypoglycemic events | None |
Once a week | |
Once a month | |
Once a year | |
HbA1c | <6% |
6%–7% | |
7%–8% | |
>8% | |
Weight change in 6 months | Gain 3 kg |
Remains the same weight | |
Loses 3 kg | |
Loses 6 kg | |
Nausea | Mild nausea for up to 3 months |
None | |
Cardiovascular risk | Decreases |
Remains the same | |
Additional payment per month | €100 |
€50 | |
€20 | |
€0 |
Abbreviation: HbA1c, glycated hemoglobin.